Novel compounds open new research avenues for Alzheimer's disease therapeutics
Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone. Although there are treatments that can slow its progression, most of them treat its symptoms only ...
Mar 13, 2026
0
18









